Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Micro-X.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: As focus turns to Delta variant, these ASX health stocks are profiting from COVID-19 testing
Health & Biotech
ASX Health Stocks: Imugene up on PD1-Vaxx cancer study expansion plans
News
Closing Bell: Energy leads the ASX to another gain, but one stock gained 265pc
Health & Biotech
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
Health & Biotech
ScoPo’s Powerplays: ‘Lots of money on sidelines waiting for pullbacks’, as all eyes are on earnings next week
News
Trading Places: Who’s betting on return to office stocks?
News
Last Orders: ASX begins FY22 down 0.65 per cent
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
News
ScoPo’s Powerplays: Mental health takes centre stage; Actinogen to progress Alzheimer’s study
Health & Biotech
Why Advanced Human and other ASX imaging stocks have more than doubled in 12 months
Health & Biotech
ScoPo’s Powerplays: The immune oncology space finally gets long overdue attention
News
Last Orders: Hump Day ends large caps down and small caps up
News
Market highlights and 5 ASX small caps to watch on Wednesday
News
Trading Places: As other ASX fundies exited CleanSpace, here’s one that sees a buy
Experts
ScoPo’s Powerplays: Budget boost and inflation fears meet head on
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
Experts
